Basics Cardiff Oncology, Inc. IPO Date: August 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $274.09M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 4.17% Avg Daily Range (30 D): $0.14 | 3.80% Avg Daily Range (90 D): $0.11 | 3.28% Institutional Daily Volume Avg Daily Volume: .87M Avg Daily Volume (30 D): 1.42M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 164 Avg Trade Size (Sh.) (30 D): 171 Avg Trade Size (Sh.) (90 D): 151 Institutional Trades Total Inst.Trades: 175 Avg Inst. Trade: $2.03M Avg Inst. Trade (30 D): $1.21M Avg Inst. Trade (90 D): $2.07M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.14M Avg Closing Trade (30 D): $1.63M Avg Closing Trade (90 D): $3.3M Avg Closing Volume: 378.1K     News Mar 8, 2025 @ 12:33 PM Why the Global Cancer Market Could Surpass $900 Bi... Source: Prnewswire Dec 10, 2024 @ 12:20 PM Cardiff Oncology Prices Oversubscribed $40 Million... Source: Globe Newswire Dec 10, 2024 @ 11:00 AM Cardiff Oncology Announces Positive Initial Data f... Source: N/A May 29, 2024 @ 8:05 PM Cardiff Oncology to Present at the Jefferies Healt... Source: Cardiff Oncology, Inc. May 13, 2024 @ 8:05 PM Cardiff Oncology to Present at Upcoming Investor C... Source: Cardiff Oncology, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.2 $-.25 $-.26 Diluted EPS $-.2 $-.25 $-.26 Revenue $ .11M $ .17M $ .16M Gross Profit $ $ $ Net Income / Loss $ -13.43M $ -11.86M $ -11.78M Operating Income / Loss $ -14.38M $ -12.6M $ -12.55M Cost of Revenue $ $ $ Net Cash Flow $ -27.38M $ -12.46M $ 6.84M PE Ratio     Splits Feb 20, 2019:   1:6 Jun 04, 2018:   1:12 May 30, 2012:   1:6